As a 501(c)(3) nonprofit, we depend almost entirely on donations from people like you.
We really need your help to continue this work! Please consider making a donation.
Subscribe here and join over 13,000 subscribers to our free weekly newsletter

Pfizer hires ex-FDA drug chief as top doctor
Key Excerpts from Article on Website of The Hill

Patrizia Cavazzoni, new Pfizer CMO. Photo: Duke Margolis via YouTube

The Hill, February 24, 2025
Posted: March 6th, 2025
https://thehill.com/policy/healthcare/5161459-former-fda-dru...

The former head of the Food and Drug Administration’s (FDA) drug division is joining Pfizer as its chief medical officer. Patrizia Cavazzoni was formerly director of the FDA’s Center for Drug Evaluation and Research (CDER) from 2020 until January, when she resigned just ahead of President Trump’s return to office. Cavazzoni previously worked at Pfizer prior to joining the FDA in 2018. The announcement spurred renewed criticisms about the common “revolving door” between the FDA and industry. Critics worry the close relationship leads to a quid pro quo and favoritism toward industry. Scott Gottlieb, FDA commissioner during Trump’s first term, now serves on the board of Pfizer. Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. has long accused the FDA of being corrupt and beholden to industry influence and has pledged to root out supposed conflicts of interest across the agency. Just ahead of the election, while Trump was considering him for HHS secretary, Kennedy posted on social media that FDA employees who are “part of this corrupt system” should “pack their bags.” Watchdog group Public Citizen panned Cavazzoni’s hiring. “Cavazonni’s move demonstrates that the revolving door between the FDA and the industries it regulates is alive and well and continues to undermine the FDA’s credibility as a public health agency,” the organization’s health research group director Robert Steinbrook said.

Note: For more along these lines, read our concise summaries of news articles on corruption in government and in Big Pharma.


Latest News


Key News Articles from Years Past